SCHEMBL22979249

SCHEMBL22979249

Cc1ccc(C#N)c(NC(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.51
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 4/20 0.51
HPGD P15428 3/20 0.51
IMPDH2 P12268 1/20 0.43
FFAR1 O14842 1/20 0.43
KMT2A Q03164 3/20 0.42
LMNA P02545 3/20 0.42
KCNMA1 Q12791 1/20 0.41
NLRP3 Q96P20 1/20 0.41
CRHR1 P34998 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 2/20 0.41
CISD2 Q8N5K1 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13481166 0.88 ALDH1A1 (0.50) GAAALDH1A1KDM4EHPGDIMPDH2
SCHEMBL404755 0.86 HPGD (0.64) GAAALDH1A1KDM4EHPGDIMPDH2
SCHEMBL22980063 0.86 ALDH1A1 (0.55) GAAALDH1A1KDM4EHPGDIMPDH2
SCHEMBL23048315 0.84 KCNMA1 (0.64) GAAALDH1A1KDM4EHPGDKMT2A
SCHEMBL7936649 0.82 KMT2A (0.46) GAAALDH1A1KDM4EHPGDKMT2A
SCHEMBL13756114 0.82 JAK3 (0.46) GAAALDH1A1KDM4EHPGDIMPDH2
SCHEMBL7505227 0.82 CYP1A2 (0.67) GAAALDH1A1KDM4EHPGDKMT2A
SCHEMBL22979643 0.81 POLB (0.44) GAAALDH1A1KDM4EHPGDFFAR1
SCHEMBL22979033 0.80 NPC1 (0.47) GAAALDH1A1KDM4EHPGDKMT2A
SCHEMBL1622373 0.80 ALDH1A1 (0.53) GAAALDH1A1KDM4EHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
EP-4013508-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES Bayer Aktiengesellschaft (DE) 2022-06-22 EP disclosed
WO-2021028382-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2021-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES AHR, HRH4, HRH1 GAA 3740/4885ALDH1A1 597/4885KDM4E 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.